THE DEAL, AT A GLANCE
From the announcementValion Bio
01Who is involvedBacked by 3iFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedValion Bio raised $7.7M Series B, announced 2026-09-01From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersValion Bio's Series B financing from 3i provides additional preferred equity and warrant-linked capital for a company with limited disclosed operating context.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Valion Bio · Financing Record
Explore source-linked visual explanations for Valion Bio. Unsupported claims are withheld while source review continues.
Record 11418 · Recorded date: 2026-09-01
Explore company records →